Medicinal chemistry of combretastatin A4: present and future directions

GC Tron, T Pirali, G Sorba, F Pagliai… - Journal of medicinal …, 2006 - ACS Publications
A growing solid tumor relies on a developing vasculature to meet its needs in terms of
oxygen, nutrients, depuration, etc. This implies that if the vascular bed that has developed …

Combretastatin A-4 analogues as antimitotic antitumor agents

NH Nam - Current medicinal chemistry, 2003 - ingentaconnect.com
Tubulin protein is a major target for anticancer drug discovery. As a result, antimitotic agents
constitute an important class of the current anticancer drugs. Hundreds of tubulin inhibitors …

BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo

CC Kuo, HP Hsieh, WY Pan, CP Chen, JP Liou, SJ Lee… - Cancer research, 2004 - AACR
BPR0L075 is a novel synthetic compound discovered through research to identify new
microtubule inhibitors. BPR0L075 inhibits tubulin polymerization through binding to the …

Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure− activity relationships and molecular modeling studies

G La Regina, MC Edler, A Brancale… - Journal of medicinal …, 2007 - ACS Publications
The new arylthioindole (ATI) derivatives 10, 14− 18, and 21− 24, which bear a halogen atom
or a small size ether group at position 5 of the indole moiety, were compared with the …

Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents

SA Patil, R Patil, DD Miller - Future medicinal chemistry, 2012 - Taylor & Francis
Agents that interfere with tubulin function have a broad anti-tumor spectrum and they
represent one of the most significant classes of anticancer agents. In the past few years …

KCC-1 supported palladium nanoparticles as an efficient and sustainable nanocatalyst for carbonylative Suzuki–Miyaura cross-coupling

P Gautam, M Dhiman, V Polshettiwar, BM Bhanage - Green Chemistry, 2016 - pubs.rsc.org
This work reports a cost-effective and sustainable protocol for the carbonylative Suzuki–
Miyaura cross-coupling reaction catalyzed by palladium nanoparticles (Pd NPs) supported …

Synthesis and in vitro antitumoral activity of new hydrazinopyrimidine-5-carbonitrile derivatives

MT Cocco, C Congiu, V Lilliu, V Onnis - Bioorganic & medicinal chemistry, 2006 - Elsevier
A new series of 2-amino-6-(2-alkyl or arylidenehydrazinyl)-4-(dialkylamino) pyrimidine-5-
carbonitriles, 5–24, were synthesized in satisfactory overall yield, using 2-amino-4 …

Concise synthesis and structure− activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin …

JP Liou, YL Chang, FM Kuo, CW Chang… - Journal of medicinal …, 2004 - ACS Publications
The synthesis and study of the structure− activity relationships of two new classes of
synthetic antitubulin compounds based on 1-aroylindole and 3-aroylindole skeletons are …

Spectroscopic (FT-IR, NMR, single crystal XRD) and DFT studies including FMO, Mulliken charges, and Hirshfeld surface analysis, molecular docking and ADME …

R Satheeshkumar, K Prabha, KN Vennila… - Journal of Molecular …, 2022 - Elsevier
In this work, synthesis, and crystal structure of molecule 2-amino-4′-fluorobenzophenone
(FAB) is confirmed by using FT-IR, FT-Raman, 1 H and 13 C NMR chemical shifts, compared …

[PDF][PDF] Combretastatin A-4 analogs as anticancer agents

A Chaudhary, SN Pandeya, P Kumar… - Mini reviews in …, 2007 - researchgate.net
Cornbretastatin A-4 (CA-4) is one of the most potent antinnitotic and antiangiogenic agents
of natural origin. It has displayed potent antitunnor effect in a wide variety of preclinical …